Dror Ortho-Design Receives FDA 510(k) Clearance for AI-Powered Sleep-Based Orthodontic System
核心洞察
Dror Ortho-Design (搜索) received FDA 510(k) clearance for its next-generation ZSmile Platform (搜索), the first FDA-cleared orthodontic system using pneumatic tooth movement (搜索) technology.
The innovative system uses a single custom smart aligner worn only during sleep, eliminating the need for 22-hour daily wear required by traditional clear aligners.
ZSmile incorporates AI-powered cloud analytics, IoT connectivity, and proprietary pulsating air technology, having been tested across more than 300 patients in clinical trials.
Dror Ortho-Design (搜索) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company's next-generation ZSmile Platform (搜索), marking a significant milestone in orthodontic technology. The Jerusalem-based company's AI-powered system represents the first and only reported FDA-cleared orthodontic solution using pneumatic tooth movement (搜索) technology, designed to work painlessly while patients sleep.
Revolutionary Sleep-Based Treatment Approach
ZSmile fundamentally differs from traditional clear aligners by delivering treatment through a single custom aligner worn only at home or during sleep. Unlike conventional systems that may require dozens of trays and up to 22 hours of daily wear, patients using ZSmile can eat, drink, speak, and engage in professional activities throughout the day with no aligner in their mouth.
"For over a decade, many clear aligners have asked patients to make the same compromises: wear plastic in your mouth for up to 22 hours a day, remove it every time you eat or drink, and hope nobody notices during meetings, presentations, or conversations," said Lee Haddad, Chief Executive Officer of Dror. "ZSmile may limit many of these compromises."
The system has been tested across more than 300 patients in clinical trials and other testing programs, with patients reporting "sleeping their way to a better smile" while functioning normally throughout the day with minimal pain, embarrassment and disruption.
Advanced Technology Integration
Building on the company's first-generation system that received FDA clearance in April 2020, the next-generation ZSmile Platform (搜索) incorporates several technological advancements:
The proprietary pulsating air technology features a redesigned micropump and motor system that quietly delivers calibrated pneumatic forces through the smart aligner for painless and effective tooth movement during sleep. AI-powered cloud analytics utilize proprietary artificial intelligence algorithms to analyze tooth movement and assist in remote monitoring capabilities for practitioners.
The IoT-connected smart aligner includes built-in Internet of Things connectivity that provides data transmission between the aligner, the patient's smartphone application, and the practitioner's dashboard, creating an integrated digital orthodontic ecosystem. An integrated mobile application serves as patients' treatment concierge, providing real-time treatment tracking, compliance monitoring, and direct communication with dental providers.
Clinical Efficacy and Target Applications
Dr. Joel Becker DMD, MSc, accredited by Hadassah School of Dentistry and Orthodontic Consultant at Dror, commented on the system's clinical performance: "In my experience with three decades of orthodontic practice and across treatment modalities from traditional braces to clear aligners, ZSmile is a significant advancement. From my assessment, the system effectively addresses Class I and Class II malocclusions with minimal discomfort and maximum discretion."
The platform is optimized for correction of malocclusions affecting the "social six" - the front upper and lower six teeth most visible when smiling. This addresses what the company believes is the largest and most commercially attractive segment of unmet demand in cosmetic orthodontics.
Market Opportunity and Commercial Strategy
The global clear aligner market is projected to exceed $56 billion by 2033 and continue growing at a double-digit compound annual rate, driven by rising consumer demand for discreet, effective smile correction solutions. Despite this growth, the fundamental technology behind clear aligners has remained largely unchanged since its introduction, relying on sequential thermoplastic trays that must be worn for the vast majority of each day.
With FDA clearance secured, Dror intends to initiate a phased U.S. commercial launch, beginning with select markets and key opinion leader practices. The company aims to create compelling practice economics for both general dentists and orthodontists by offering a differentiated treatment option that can expand patient volume and drive incremental revenue.
ZSmile has previously received CE marking and Israeli regulatory approval, positioning the company for international expansion across multiple high-value markets, including Europe and the Middle East. The single-aligner treatment model reduces material waste, practitioner chair time, and perceived patient burden compared to conventional systems requiring dozens of sequential trays.